Pulmonx Corp
LUNG- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001127537
In the last 90 days, Pulmonx Corp insiders filed 0 open-market purchases and 4 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $34.1M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Pulmonx Corp as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 117
- +2 vs. Q2 2023
- Shares held
- 33.3M
- −567.3K (−1.7%) vs. Q2 2023
- Total value
- $343.8M
- −$100.2M (−22.6%) vs. Q2 2023
- New holders
- 11
- 39 more added
- Sold out
- 9
- 44 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LUNG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 107 | $34.1M |
| Q1 2026 | 114 | $41.0M |
| Q4 2025 | 112 | $71.6M |
| Q3 2025 | 107 | $51.6M |
| Q2 2025 | 114 | $93.9M |
| Q1 2025 | 115 | $244.3M |
| Q4 2024 | 118 | $243.6M |
| Q3 2024 | 113 | $293.8M |
| Q2 2024 | 112 | $220.5M |
| Q1 2024 | 118 | $321.4M |
| Q4 2023 | 124 | $427.6M |
| Q3 2023 | 117 | $343.8M |
| Q2 2023 | 115 | $444.0M |
| Q1 2023 | 102 | $388.0M |
| Q4 2022 | 116 | $284.6M |
| Q3 2022 | 104 | $581.4M |
| Q2 2022 | 107 | $520.2M |
| Q1 2022 | 109 | $861.1M |
| Q4 2021 | 114 | $1.03B |
| Q3 2021 | 120 | $1.14B |
| Q2 2021 | 113 | $1.14B |
| Q1 2021 | 110 | $988.2M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Pulmonx Corp; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rock Springs Capital Management LP | 652,400 | $6.74M | 0.18% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 668,358 | $6.90M | 0.01% | −48,020−6.7% | Reduced |
| Pura Vida Investments, LLC | 726,298 | $7.50M | 3.69% | +89,890+14.1% | Added |
| Franklin Resources Inc | 743,873 | $7.68M | 0.00% | +2860.0% | Added |
| Geode Capital Management, LLC | 764,367 | $7.90M | 0.00% | +27,374+3.7% | Added |
| State Street Corp | 860,423 | $8.89M | 0.00% | −127,193−12.9% | Reduced |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 897,525 | $9.27M | 0.03% | −10,267−1.1% | Reduced |
| Victory Capital Management Inc | 950,763 | $9.82M | 0.01% | −26,581−2.7% | Reduced |
| Braidwell LP | 988,559 | $10.2M | 0.32% | −10,803−1.1% | Reduced |
| KPCB XIII Associates, LLC | 994,971 | $10.3M | 5.53% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 1,017,958 | $10.5M | 0.23% | −46,327−4.4% | Reduced |
| Vanguard Group Inc | 2,023,836 | $20.9M | 0.00% | +19,364+1.0% | Added |
| FMR LLC | 2,029,835 | $21.0M | 0.00% | +401,830+24.7% | Added |
| Morgan Stanley | 2,219,826 | $22.9M | 0.00% | +246,302+12.5% | Added |
| Point72 Asset Management, L.P. | 2,929,903 | $30.3M | 0.10% | −396,162−11.9% | Reduced |
| BlackRock Inc. | 2,935,660 | $30.3M | 0.00% | +23,894+0.8% | Added |
| Primecap Management Co | 5,522,401 | $57.0M | 0.05% | +2,6800.0% | Added |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −41,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −29,885−100.0% | Sold out |
| Weiss Multi-Strategy Advisers LLC | 0 | $0 | 0.00% | −28,977−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −26,293−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −18,232−100.0% | Sold out |
| Keebeck Alpha, LP | 0 | $0 | 0.00% | −13,210−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −11,711−100.0% | Sold out |
| Cresset Asset Management, LLC | 0 | $0 | 0.00% | −10,635−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −1,410−100.0% | Sold out |